Gilead's stock price increases by 10% by Q3 2024? | Binary | | | 6 months ago | |
Sunlenca available to consumers by Q1 2025? | Binary | | | 6 months ago | |
FDA Approval of Sunlenca by end of 2024? | Binary | | | 6 months ago | |
Will Sunlenca be FDA approved for HIV prevention by end of 2024? | Binary | | | 6 months ago | |
Will Gilead's stock price increase by more than 20% by end of 2024? | Binary | | | 6 months ago | |
Will Sunlenca be added to WHO's List of Essential Medicines by mid-2025? | Binary | | | 6 months ago | |
Will Gilead's stock price increase by 10% or more by the end of 2024? | Binary | | | 3 months ago | |
Will Gilead's Lenacapavir receive FDA approval for HIV prevention by end of 2024? | Binary | | | 3 months ago | |
Will Gilead's stock price increase by at least 10% within one week of FDA approval of Lenacapavir? | Binary | | | 3 months ago | |
Sunlenca vs. Truvada market share by end of 2025? | Categorical | | | 6 months ago | |
What will be Sunlenca's market share in HIV prevention drugs by end of 2024? | Categorical | | | 6 months ago | |
What percentage of market share will Lenacapavir capture in the HIV prevention market by the end of 2025? | Categorical | | | 3 months ago | |
Will Lenacapavir receive regulatory approval in the US by mid-2025? | Binary | | | 3 months ago | |
Will Gilead file for regulatory approval for Lenacapavir by the end of 2024? | Binary | | | 3 months ago | |
What will be the price range of Lenacapavir in its first year of launch? | Categorical | | | 3 months ago | |
How many regulatory approvals will Lenacapavir receive by the end of 2025? | Categorical | | | 3 months ago | |
What will be the market share of Lenacapavir compared to Truvada by end of 2025? | Categorical | | | 3 months ago | |
What will be the revenue generated by Lenacapavir in its first full year of sales by end of 2025? | Categorical | | | 3 months ago | |
Will Gilead's Lenacapavir be included in WHO's list of essential medicines by end of September 2025? | Binary | | | 3 months ago | |
How many countries will approve Lenacapavir for HIV prevention by end of 2024? | Categorical | | | 3 months ago | |
Sunlenca global market adoption by mid-2025? | Categorical | | | 6 months ago | |
How many participants will be enrolled in post-approval studies of Sunlenca by end of 2024? | Categorical | | | 6 months ago | |
How many countries will approve Sunlenca for HIV prevention by end of 2024? | Categorical | | | 6 months ago | |
Number of countries approving Sunlenca by end of 2024? | Categorical | | | 6 months ago | |
